Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Methods ; 60(3): 275-83, 2013 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-23459257

RESUMO

Nanoparticles (NP) possess remarkable adjuvant and carrier capacity, therefore are used in the development of various vaccine formulations. Our previous studies demonstrated that inert non-toxic 40-50 nm polystyrene NP (PS-NP) can promote strong CD8 T cell and antibody responses to the antigen, in the absence of observable inflammatory responses. Furthermore, instillation of PS-NP inhibited the development of allergic airway inflammation by induction of an immunological imprint via modulation of dendritic cell (DC) function without inducing oxidative stress in the lungs in mice. This is in contrast to many studies which show that a variety of ambient and man-made NP promote lung immunopathology, raising concerns generally about the safe use of NPs in biomedicine. Most NPs are capable of inducing inflammatory pathways in DC largely mediated by signalling via the extracellular signal-regulated kinase 1/2 (ERK). Herein, we investigate whether PS-NPs also activate ERK in DC in vitro. Our data show that PS-NP do not induce ERK activation in two different types of bone marrow derived (BM) DC cultures (expanded with GM-CSF or with GM-CSF together with IL-4). The absence of such signalling was not due to lack of PS-NP uptake by BM-DC as confirmed by confocal microscopy and flow cytometry. The process of NP uptake by DC usually initiates ERK signalling, suggesting an unusual uptake pathway may be engaged by PS-NPs. Indeed, data herein showns that uptake of PS-NP by BM-DC was substantially inhibited by phorbol myristate acetate (PMA) but not cytochalasin D (CCD), suggesting an uptake pathway utilising caveole for PS-NP. Together these data show that BM-DC take up PS-NP via a caveole-dependent pathway which does not trigger ERK signalling which may explain their efficient uptake by DC, without the concomitant activation of conventional inflammatory pathways.


Assuntos
Antígenos/imunologia , Células da Medula Óssea/efeitos dos fármacos , Linfócitos T CD8-Positivos/efeitos dos fármacos , Células Dendríticas/efeitos dos fármacos , Nanopartículas/química , Poliestirenos/imunologia , Transdução de Sinais/efeitos dos fármacos , Vacinas Sintéticas/imunologia , Animais , Células da Medula Óssea/citologia , Células da Medula Óssea/imunologia , Linfócitos T CD8-Positivos/citologia , Linfócitos T CD8-Positivos/imunologia , Cavéolas/imunologia , Células Cultivadas , Citocinas/deficiência , Citocinas/imunologia , Células Dendríticas/citologia , Células Dendríticas/imunologia , MAP Quinases Reguladas por Sinal Extracelular/genética , MAP Quinases Reguladas por Sinal Extracelular/imunologia , Regulação da Expressão Gênica , Fator Estimulador de Colônias de Granulócitos e Macrófagos/farmacologia , Imunoconjugados/química , Imunoconjugados/imunologia , Imunoconjugados/farmacologia , Interleucina-4/farmacologia , Pulmão/citologia , Pulmão/imunologia , Camundongos , Camundongos Endogâmicos C57BL , Poliestirenos/química , Transdução de Sinais/imunologia , Acetato de Tetradecanoilforbol/farmacologia , Vacinas Sintéticas/química , Vacinas Sintéticas/farmacologia
2.
Expert Rev Vaccines ; 9(6): 595-600, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20518715

RESUMO

A successful vaccine for immunotherapy, particularly for solid tumors or viral infections, requires a suitable target antigen and the production of a cytotoxic T-cell response. In addition, CD4 T cells play an important role in cellular immunity. Here, we briefly discuss methods by which T cells are measured in vitro after vaccination.


Assuntos
Vacinas Anticâncer/imunologia , Neoplasias/terapia , Linfócitos T/imunologia , Animais , Linfócitos T CD4-Positivos/imunologia , Células-Tronco Hematopoéticas/imunologia , Humanos , Neoplasias/imunologia , Ovalbumina/imunologia , Linfócitos T Citotóxicos/imunologia , Vacinação
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa